Heather Bausell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Heather Bausell has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- André L. Santos Pessoa
Albert Sabin Children’s Hospital, R. Tertuliano Sales, 544—Vila União, Fortaleza 60410-794, CE, Brazil
1 shared publication - Ania Carolina Muntau
Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland
1 shared publication - Anita Inwood
Queensland Lifespan Metabolic Medicine Service, Queensland Children’s Hospital, 501 Stanley St., South Brisbane, QLD 4101, Australia
1 shared publication Caroline Eggerding
Cooper University Health Care, Camden, NJ, USA
1 shared publication- Cary O. Harding
Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA
1 shared publication - Danielle Starin
Rare Disease Institute, Children's National, Washington, DC, USA
1 shared publication
Latest Publications
- Open Access
Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria
Many adults with phenylketonuria (PKU) rely on medical nutrition therapy (MNT; low phenylalanine (Phe) diet with protein substitutes/medical foods) to maintain blood Phe concentrations within recommended ranges and prevent PKU-associated comorbidities. Despite disease detection through newborn screening and introduction of MNT as early as birth, adherence to MNT often deteriorates from childhood onwards, complicating the assessment of its effectiveness in the long term. Via a modified Delphi process, consensus (≥70% agreement) was sought on 19 statements among an international, multidisciplinary 13-member expert panel. After three iterative voting rounds, the panel achieved consensus on 17 statements related to the limitations of the long-term effectiveness of MNT (7), the burden of long-term reliance on MNT (4), and its potential long-term detrimental health effects (6). According to the expert panel, the effectiveness of MNT is limited in the long term, is associated with a high treatment burden, and demonstrates that adults with PKU are often unable to achieve metabolic control through dietary management alone, creating an unmet need in the adult PKU population.
Open AccessExpert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria
Many adults with phenylketonuria (PKU) rely on medical nutrition therapy (MNT; low phenylalanine (Phe) diet with protein substitutes/medical foods) to maintain blood Phe concentrations within recommended ranges and prevent PKU-associated comorbidities. Despite disease detection through newborn screening and introduction of MNT as early as birth, adherence to MNT often deteriorates from childhood onwards, complicating the assessment of its effectiveness in the long term. Via a modified Delphi process, consensus (≥70% agreement) was sought on 19 statements among an international, multidisciplinary 13-member expert panel. After three iterative voting rounds, the panel achieved consensus on 17 statements related to the limitations of the long-term effectiveness of MNT (7), the burden of long-term reliance on MNT (4), and its potential long-term detrimental health effects (6). According to the expert panel, the effectiveness of MNT is limited in the long term, is associated with a high treatment burden, and demonstrates that adults with PKU are often unable to achieve metabolic control through dietary management alone, creating an unmet need in the adult PKU population.
- Open Access
- 14 August 2021
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 28, 100790
Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics
- 14 August 2021
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 28, 100790
Open AccessUse of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics